16 companies 13 industries value 350 bn revenue 291 bn
| Rank | Ticker | Company | Value | Revenue | Margin | FCF | 5 years | FCF/px | Yield | What it does · why it is here |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | TTE | TotalEnergies Integrated oil · score 7.9 | 199 bn | 215 bn | 8.4% | 33 bn | 16.6% | 4.5% | Oil, gas, LNG and low-carbon electricity · Biggest investor in renewables among the integrated oil majors | |
| 2 | SNY | Sanofi European pharmaceuticals · score 6.8 | 97 bn | 51 bn | 8.7% | 13 bn | 13.8% | — | Medicines and vaccines, with Dupixent, from France · Dupixent, one of the world's fastest-growing drugs; strong in vaccines | |
| 3 | STM | STMicroelectronics Analog and industrial semiconductors · score 6.6 | 41 bn | 12 bn | 1.4% | 2.1 bn | 5.3% | 0.8% | Semiconductors for automotive and industrial, from Switzerland · Major European supplier to the automotive and industrial markets | |
| 4 | ABVX | Abivax S.A. Clinical-stage pharmaceuticals · score 0.0 | 6.9 bn | 0.0 bn | -80x | -0.2 bn | -3.2% | — | Therapies for chronic inflammatory diseases, from France · France — revenue of $6m | |
| 5 | CSTM | Constellium Aluminum · score 5.6 | 3.5 bn | 9.6 bn | 5.7% | 0.2 bn | 6.3% | — | Rolled and extruded aluminum products, from France · Rolled aluminum products for cans, automotive and aerospace | |
| 6 | NBTX | Nanobiotix S.A. Clinical-stage pharmaceuticals · score 0.0 | 1.0 bn | 0.0 bn | -42.6% | -0.0 bn | -3.9% | — | Nanoparticle-enhanced radiotherapy, from France · France — revenue of $13m | |
| 7 | CRTO | Criteo Digital advertising (adtech) · score 6.8 | 0.7 bn | 1.9 bn | 5.6% | 0.2 bn | 23.8% | — | Personalized advertising and shopping retargeting · Retargeting advertising and retail media | |
| 8 | IVA | Inventiva S.A. Clinical-stage pharmaceuticals · score 0.0 | 0.7 bn | 0.0 bn | -5051x | -0.1 bn | -15.4% | — | Medicines for liver diseases, from France · France | |
| 9 | VALN | Valneva SE Vaccines and mRNA · score 0.0 | 0.5 bn | 0.2 bn | -110.3% | -0.1 bn | -13.6% | — | Vaccines for infectious diseases, from France · France — revenue of $160m | |
| 10 | HKD | AMTD Digital Inc. Journalism and digital media · score 4.3 | 0.5 bn | 0.1 bn | 71.3% | 0.0 bn | 2.7% | — | Digital and media services, from Hong Kong · France — revenue of $136m | |
| 11 | DBVT | DBV Technologies S.A. Clinical-stage pharmaceuticals · score 0.0 | 0.5 bn | 0.0 bn | -35x | -0.2 bn | -32.1% | — | Late-stage immunotherapy biopharma with the Viaskin platform · France — revenue of $5m | |
| 12 | IPHA | Innate Pharma SA Clinical-stage biotech · score 0.0 | 0.2 bn | 0.0 bn | -483.8% | -0.1 bn | -29.4% | — | NK cell antibody oncology, from France · France — revenue of $11m | |
| 13 | CLLS | Cellectis S.A. Biotechnology · score 0.0 | 0.1 bn | 0.1 bn | -115.4% | -0.0 bn | -47.2% | — | Allogeneic CAR-T cell immunotherapy, from France · France — revenue of $57m | |
| 14 | AMTD | AMTD IDEA GROUP Diversified holding companies · score 4.9 | 0.0 bn | 0.1 bn | 66.4% | 0.0 bn | 21x | — | Financial and digital media services, from Hong Kong · France — assets of $2.3bn | |
| 15 | SQNS | SEQUANS COMMUNICATIONS RF and mobile chips · score 0.0 | 0.0 bn | 0.0 bn | -415.1% | -0.0 bn | -73.2% | — | Cellular connectivity chips for the Internet of Things, from France · France — revenue of $26m | |
| 16 | FOCL | EDAP TMS SA Robotic surgery and advanced medtech · score 0.6 | — | 0.1 bn | -49.1% | -0.0 bn | — | — | Ultrasound equipment for prostate cancer treatment, from France · France — revenue of $79m |
By sector
| Sector | Companies | Value | Revenue | Largest |
|---|---|---|---|---|
| Health Care | 9 | 106 bn | 52 bn | SNY, ABVX, NBTX |
| Information Technology | 2 | 41 bn | 12 bn | STM, SQNS |
| Communication Services | 2 | 1.2 bn | 2.0 bn | CRTO, HKD |
| Energy | 1 | 199 bn | 215 bn | TTE |
| Materials | 1 | 3.5 bn | 9.6 bn | CSTM |
| Financials | 1 | — | 0.1 bn | AMTD |
Companies by country
- All countries
- United States 3,893 companies
- China 234 companies
- Canada 209 companies
- Israel 104 companies
- Singapore 89 companies
- Hong Kong 82 companies
- United Kingdom 78 companies
- Switzerland 32 companies
- Brazil 31 companies
- Ireland 31 companies
- Australia 29 companies
- Bermuda 28 companies
- Japan 28 companies
- Greece 26 companies
- Netherlands 19 companies
- Taiwan 19 companies
- Cayman Islands 18 companies
- Germany 17 companies
- Mexico 17 companies
- Argentina 16 companies
- Malaysia 16 companies
- South Korea 14 companies
- Luxembourg 12 companies
- India 9 companies
- Belgium 8 companies
- Sweden 8 companies
- United Arab Emirates 8 companies
- Chile 7 companies
- South Africa 7 companies
- Spain 7 companies
- Denmark 6 companies
- Italy 6 companies
- Cyprus 5 companies
- Jersey 5 companies
- Colombia 4 companies
- Monaco 4 companies
- Peru 4 companies
- Norway 3 companies
- Turkey 3 companies
- Uruguay 3 companies
- British Virgin Islands 2 companies
- Costa Rica 2 companies
- Guernsey 2 companies
- Indonesia 2 companies
- Panama 2 companies
- Philippines 2 companies
- Bahamas 1 company
- Cambodia 1 company
- Finland 1 company
- Gibraltar 1 company
- Isle of Man 1 company
- Jordan 1 company
- Kazakhstan 1 company
- Macau 1 company
- Thailand 1 company
- Vietnam 1 company
What this is. A catalogue, not a guide. Every industry with stocks listed on the NYSE or NASDAQ, the companies contending for its leadership, what each one does according to its own annual report, and the balance sheet it filed with the SEC.
The score runs from 0 to 10 and compares each company with every other one in the almanac on cash generation, profitability, debt, dividends and consistency over the last five years. The higher it is, the better the company fares in that comparison. Curious how much each part weighs? Ask at the bottom of the page.
The score runs from 0 to 10 and compares each company with every other one in the almanac on cash generation, profitability, debt, dividends and consistency over the last five years. The higher it is, the better the company fares in that comparison. Curious how much each part weighs? Ask at the bottom of the page.